Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154711 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 40
- Enrollment target
NCT02154711: Completed study, sponsored by University of Pennsylvania.
NCT02154711 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154711 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to use a new research imaging technique, a kind of magnetic resonance imaging (MRI), to measure important metabolic features of muscle, including mitochondrial function, in people with mitochondrial disease and in healthy individuals. (Mitochondria are tiny organelles that generate energy for the body.) It is hoped that this new strategy will help physicians to understand better the health problems of people with mitochondrial disease. Eventually, this could lead to better diagnostic and treatment approaches.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-05 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02154711
The ClinicalTrials.gov registry entry for NCT02154711 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02154711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02154711 about?
NCT02154711 is a clinical study titled "Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease". The purpose of the study is to use a new research imaging technique, a kind of magnetic resonance imaging (MRI), to measure important metabolic features of muscle, including mitochondrial function, in people with mitochondrial disease and in healthy individuals. (Mitochondria are tiny organelles tha...
What is the current status of trial NCT02154711?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-05. Estimated completion is 2020-06-30.
Who is sponsoring clinical trial NCT02154711?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.